Publications

Browse our publications catalogue to learn about our research.

Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations

Nalyaka Sambu & N. Curzen, 2011, British Journal of Clinical Pharmacology, 72(4), 683-696

DOI: 10.1111/j.1365-2125.2011.03955.x

Type: article

The effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single centre CESSATION study

Nalyaka Sambu, Hazel Dent, Nicola Englyst, Timothy D. Warner, Philip Leadbeater, Paul Roderick, Huon Gray, Iain Simpson, Simon Corbett, Alison Calver, John Morgan & Nick Curzen, 2011, Heart, 97(20), 1661-1667

DOI: 10.1136/heartjnl-2011-300192

Type: article

Correspondence. Dynamic left ventricular outflow tract obstruction and acute heart failure in tako-tsubo cardiomyopathy

B.N. Shah & Nick Curzen, 2011, Journal of the American College of Cardiology, 58(11), 1195-1196

DOI: 10.1016/j.jacc.2011.03.062

Type: article

Reversible systolic anterior motion of the mitral valve and left ventricular outflow tract obstruction in association with Takotsubo syndrome

B.N. Shah & Nick Curzen, 2011, Echocardiography, 28(8), 921-924

DOI: 10.1111/j.1540-8175.2011.01446.x

Type: article

The extent of left ventricular scar quantified by late gadolinium enhancement mri is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators

Paul A. Scott, John M. Morgan, Nicola Carroll, David C. Murday, Paul R. Roberts, Charles R. Peebles, Stephen P. Harden & Nick P. Curzen, 2011, Circulation: Arrhythmia and Electrophysiology, 4(3), 324-330

DOI: 10.1161/?CIRCEP.110.959544

Type: article

"Short" thrombelastography as a test of platelet reactivity in response to antiplatelet therapy: validation and reproducibility

Nalyaka Sambu, Alex Hobson & Nick Curzen, 2011, Platelets, 22(3), 210-216

DOI: 10.3109/09537104.2010.543201

Type: article

A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prosprective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element) for the treatment of up to two de Novo coronary artery lesions) Trial

Gregg W. Stone, Paul S. Teirstein, I.T. Meredith, B. Farah, C.L. Dubois, R.L. Feldman, Joseph Dens, Nobuhisa Hagiwara, Dominic J. Allocco, Keith D. Dawkins & Nicholas Curzen, 2011, Journal of the American College of Cardiology, 57(16), 1700-1708

DOI: 10.1016/j.jacc.2011.02.016

Type: article